[1]
Kabir, A. 2024. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Bangladesh Journal of Medicine. 35, 20 (Jun. 2024), 165. DOI:https://doi.org/10.3329/bjm.v35i20.73432.